Literature DB >> 27267376

Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol.

Reesha R Patel1, Cindy Barbosa2, Tatiana Brustovetsky2, Nickolay Brustovetsky3, Theodore R Cummins4.   

Abstract

Mutations in brain isoforms of voltage-gated sodium channels have been identified in patients with distinct epileptic phenotypes. Clinically, these patients often do not respond well to classic anti-epileptics and many remain refractory to treatment. Exogenous as well as endogenous cannabinoids have been shown to target voltage-gated sodium channels and cannabidiol has recently received attention for its potential efficacy in the treatment of childhood epilepsies. In this study, we further investigated the ability of cannabinoids to modulate sodium currents from wild-type and epilepsy-associated mutant voltage-gated sodium channels. We first determined the biophysical consequences of epilepsy-associated missense mutations in both Nav1.1 (arginine 1648 to histidine and asparagine 1788 to lysine) and Nav1.6 (asparagine 1768 to aspartic acid and leucine 1331 to valine) by obtaining whole-cell patch clamp recordings in human embryonic kidney 293T cells with 200 μM Navβ4 peptide in the pipette solution to induce resurgent sodium currents. Resurgent sodium current is an atypical near threshold current predicted to increase neuronal excitability and has been implicated in multiple disorders of excitability. We found that both mutations in Nav1.6 dramatically increased resurgent currents while mutations in Nav1.1 did not. We then examined the effects of anandamide and cannabidiol on peak transient and resurgent currents from wild-type and mutant channels. Interestingly, we found that cannabidiol can preferentially target resurgent sodium currents over peak transient currents generated by wild-type Nav1.6 as well as the aberrant resurgent and persistent current generated by Nav1.6 mutant channels. To further validate our findings, we examined the effects of cannabidiol on endogenous sodium currents from striatal neurons, and similarly we found an inhibition of resurgent and persistent current by cannabidiol. Moreover, current clamp recordings show that cannabidiol reduces overall action potential firing of striatal neurons. These findings suggest that cannabidiol could be exerting its anticonvulsant effects, at least in part, through its actions on voltage-gated sodium channels, and resurgent current may be a promising therapeutic target for the treatment of epilepsy syndromes.
© The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Dravet syndrome; GEFS+; VGSC; cannabidiol; resurgent current

Mesh:

Substances:

Year:  2016        PMID: 27267376      PMCID: PMC4958898          DOI: 10.1093/brain/aww129

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  72 in total

Review 1.  Resurgent Na+ current: a new avenue to neuronal excitability control.

Authors:  Jader S Cruz; Darizy F Silva; Luciano A Ribeiro; Islânia G A Araújo; Nayara Magalhães; Alessandra Medeiros; Christiane Freitas; Izabella C Araujo; Fernando A Oliveira
Journal:  Life Sci       Date:  2011-06-13       Impact factor: 5.037

2.  Impaired inactivation gate stabilization predicts increased persistent current for an epilepsy-associated SCN1A mutation.

Authors:  Kristopher M Kahlig; Sunita N Misra; Alfred L George
Journal:  J Neurosci       Date:  2006-10-25       Impact factor: 6.167

3.  Nav1.7 mutations associated with paroxysmal extreme pain disorder, but not erythromelalgia, enhance Navbeta4 peptide-mediated resurgent sodium currents.

Authors:  Jonathan W Theile; Brian W Jarecki; Andrew D Piekarz; Theodore R Cummins
Journal:  J Physiol       Date:  2010-11-29       Impact factor: 5.182

4.  Impaired action potential initiation in GABAergic interneurons causes hyperexcitable networks in an epileptic mouse model carrying a human Na(V)1.1 mutation.

Authors:  Ulrike B S Hedrich; Camille Liautard; Daniel Kirschenbaum; Martin Pofahl; Jennifer Lavigne; Yuanyuan Liu; Stephan Theiss; Johannes Slotta; Andrew Escayg; Marcel Dihné; Heinz Beck; Massimo Mantegazza; Holger Lerche
Journal:  J Neurosci       Date:  2014-11-05       Impact factor: 6.167

5.  Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy.

Authors:  Frank H Yu; Massimo Mantegazza; Ruth E Westenbroek; Carol A Robbins; Franck Kalume; Kimberly A Burton; William J Spain; G Stanley McKnight; Todd Scheuer; William A Catterall
Journal:  Nat Neurosci       Date:  2006-08-20       Impact factor: 24.884

6.  Sudden unexpected death in a mouse model of Dravet syndrome.

Authors:  Franck Kalume; Ruth E Westenbroek; Christine S Cheah; Frank H Yu; John C Oakley; Todd Scheuer; William A Catterall
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

Review 7.  Resurgent current of voltage-gated Na(+) channels.

Authors:  Amanda H Lewis; Indira M Raman
Journal:  J Physiol       Date:  2014-08-28       Impact factor: 5.182

Review 8.  Divergent effects of the T1174S SCN1A mutation associated with seizures and hemiplegic migraine.

Authors:  Sandrine Cestèle; Angelo Labate; Raffaella Rusconi; Patrizia Tarantino; Laura Mumoli; Silvana Franceschetti; Grazia Annesi; Massimo Mantegazza; Antonio Gambardella
Journal:  Epilepsia       Date:  2013-02-08       Impact factor: 5.864

9.  Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.

Authors:  F M Leweke; D Piomelli; F Pahlisch; D Muhl; C W Gerth; C Hoyer; J Klosterkötter; M Hellmich; D Koethe
Journal:  Transl Psychiatry       Date:  2012-03-20       Impact factor: 6.222

10.  Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach.

Authors:  Ragna S Boerma; Kees P Braun; Marcel P H van den Broek; Maarten P H van de Broek; Frederique M C van Berkestijn; Marielle E Swinkels; Eveline O Hagebeuk; Dick Lindhout; Marjan van Kempen; Maartje Boon; Joost Nicolai; Carolien G de Kovel; Eva H Brilstra; Bobby P C Koeleman
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

View more
  50 in total

1.  Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers.

Authors:  Shanna Babalonis; Margaret Haney; Robert J Malcolm; Michelle R Lofwall; Victoria R Votaw; Steven Sparenborg; Sharon L Walsh
Journal:  Drug Alcohol Depend       Date:  2016-12-14       Impact factor: 4.492

2.  Cannabidiol protects against high glucose-induced oxidative stress and cytotoxicity in cardiac voltage-gated sodium channels.

Authors:  Mohamed A Fouda; Mohammad-Reza Ghovanloo; Peter C Ruben
Journal:  Br J Pharmacol       Date:  2020-03-10       Impact factor: 8.739

3.  Cannabidiol Mellows Out Resurgent Sodium Current.

Authors:  Christopher H Thompson; Jennifer A Kearney
Journal:  Epilepsy Curr       Date:  2016 Nov-Dec       Impact factor: 7.500

Review 4.  Cannabis for the Treatment of Epilepsy: an Update.

Authors:  Tyler E Gaston; Jerzy P Szaflarski
Journal:  Curr Neurol Neurosci Rep       Date:  2018-09-08       Impact factor: 5.081

5.  De novo and inherited SCN8A epilepsy mutations detected by gene panel analysis.

Authors:  Kameryn M Butler; Cristina da Silva; Yuval Shafir; James D Weisfeld-Adams; John J Alexander; Madhuri Hegde; Andrew Escayg
Journal:  Epilepsy Res       Date:  2016-11-06       Impact factor: 3.045

6.  Reefer to the Rescue: The Dope on Cannabidiol as a Multi-Symptom Panacea for Dravet Syndrome.

Authors:  Akshay Gupta; Viji Santhakumar
Journal:  Epilepsy Curr       Date:  2018 Mar-Apr       Impact factor: 7.500

7.  Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP).

Authors:  Brian D Klein; Catherine A Jacobson; Cameron S Metcalf; Misty D Smith; Karen S Wilcox; Aidan J Hampson; John H Kehne
Journal:  Neurochem Res       Date:  2017-05-06       Impact factor: 3.996

8.  Pro-excitatory alterations in sodium channel activity facilitate subiculum neuron hyperexcitability in temporal lobe epilepsy.

Authors:  Bryan S Barker; Aradhya Nigam; Matteo Ottolini; Ronald P Gaykema; Nicholas J Hargus; Manoj K Patel
Journal:  Neurobiol Dis       Date:  2017-08-30       Impact factor: 5.996

9.  Prominent role of forebrain excitatory neurons in SCN8A encephalopathy.

Authors:  Rosie K A Bunton-Stasyshyn; Jacy L Wagnon; Eric R Wengert; Bryan S Barker; Alexa Faulkner; Pravin K Wagley; Kritika Bhatia; Julie M Jones; Marissa R Maniaci; Jack M Parent; Howard P Goodkin; Manoj K Patel; Miriam H Meisler
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

Review 10.  Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and Related Comorbidities.

Authors:  Dinesh Upadhya; Olagide W Castro; Raghavendra Upadhya; Ashok K Shetty
Journal:  Mol Neurobiol       Date:  2018-01-25       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.